Aducanumab: Appropriate Use Recommendations
Document Type
Article
Publication Date
7-27-2021
Publication Title
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
First page number:
1
Last page number:
3
Abstract
Aducanumab recently received accelerated approval by the FDA. An Expert Panel was comprised to provide recommendations on appropriate use of aducanumab in real world practices. Patient selection, aducanumab administration and monitoring, management of ARIA, and best practices in patient care in the context of aducanumab therapy are described. The paper was published in the Journal of Prevention of Alzheimer's Disease.
Keywords
Aducanumab; Aduhelm; Alzheimer’s disease; Amyloid imaging; Appropriate use; Aria; MRI; Titration
Disciplines
Cognitive Neuroscience
Language
English
Repository Citation
Cummings, J.,
Salloway, S.
(2021).
Aducanumab: Appropriate Use Recommendations.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
1-3.
http://dx.doi.org/10.1002/alz.12444